Real-World Outcomes Among Patients in the United States Receiving Tafamidis for Transthyretin Amyloid Cardiomyopathy. [PDF]
Judge DP +6 more
europepmc +1 more source
Monitoring Disease Progression in Transthyretin Amyloid Cardiomyopathy. [PDF]
Ioannou A.
europepmc +1 more source
Multimodality imaging of transthyretin amyloid cardiomyopathy
Majda, Anna Patrycja +5 more
openaire +3 more sources
Transthyretin amyloid cardiomyopathy: natural history and treatment response assessed by cardiovascular magnetic resonance. [PDF]
Patel RK +20 more
europepmc +1 more source
A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy. [PDF]
Gillmore JD +24 more
europepmc +1 more source
Efficacy and safety of vutrisiran in transthyretin amyloid cardiomyopathy across the age spectrum: The HELIOS-B trial. [PDF]
Sheikh A +8 more
europepmc +1 more source
Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy: When the Heart Isn't the Only Matter. [PDF]
Zeis T +6 more
europepmc +1 more source
Incidental Cardiac Uptake on 99mTc-HMDP Bone Scintigraphy in Oncology Patients: Two Cases of Transthyretin Amyloid Cardiomyopathy with Literature Review. [PDF]
Matsuki N +6 more
europepmc +1 more source
Staging Cardiac Amyloidosis With CMR Understanding the Different Phenotypes [PDF]
Fontana, M +2 more
core
Contemporary Oral Medication Use and Frequency in Patients with Transthyretin Amyloid Cardiomyopathy. [PDF]
Dasgupta N +12 more
europepmc +1 more source

